Case Study: PharmChem, Inc. (OTC: PCHM) - Demystifying MicroCap Myths | Avoiding the Crowd •Oct 27, 2020
On this episode of Avoiding the Crowd with Maj Soueidan, there are many myths around MicroCap Stocks that many investors use as excuses to not invest in this asset class - not enough liquidity, usually little to no revenues, poor quality management teams, no dividend; the list goes on. We thought it would be fun to use a case study on a company that demystifies some of these myths - one that has been a very successful investment for Maj. Using his investing experience in PharmChem, Inc. (OTC: PCHM), which he still owns, Maj demonstrates how a non-fully reporting, revenue generating, profitable, dividend paying, illiquid OTC company with a stop sign has worked out for his portfolio. Please enjoy!
Market Data 
Markets 
AI
